Stanford Medicine researchers recently released preliminary results of the Apple Heart Study, the largest study ever of its kind, which enrolled over 400,000 participants from all 50 states in a span of only eight months.
Apple Heart Study Overview
Presented at American College of Cardiology’s 68th Annual Scientific Session and Expo in New Orleans, the study was launched in 2017 to evaluate Apple Watch’s irregular rhythm notification, which occasionally checks the heart's rhythm in the
Read More
UMass Lowell Awarded $1M Grant to Develop Secure Cyberinfrastructure for Translational Research
The National Science Foundation (NSF) has awarded a three-year grant totaling nearly $1 million to a team of UMass Lowell researchers led by Prof. Yan Luo of UMass Lowell's Department of Electrical and Computer Engineering to develop a secure cyberinfrastructure for translational research. Luo's fellow researchers on the project are Associate Prof. Yu Cao of UMass Lowell's Computer Science Department, along with colleagues Assistant Prof. Peilong Li of Elizabethtown College and Prof. Silvia
Read More
Cognoa Awarded FDA Breakthrough Designations for Diagnostic and Digital Therapeutic Devices for Autism
Cognoa, a digital health company focused on behavioral health for children, today announced FDA Breakthrough designations for it's first diagnostic and therapeutic devices to identify and treat autism. This is the foundation for its AI-based digital precision health to support the developmental and behavioral health of children, combining diagnostics and therapeutics into one platform. This signifies a big step in the company’s expansion into therapeutics.FDA Breakthrough Devices Program
Read More
XIFIN Enters Precision Medicine Market With Launch of VisualStrata
XIFIN has announced the launch of its precision medicine informatics platform, VisualStrata, to help healthcare professionals gain deeper insights into optimal disease treatments and drive personalized care decisions. VisualStrata is the only precision medicine informatics tool that uniquely curates and visualizes diagnostic, clinical and financial data to document the patient journey through diagnosis, treatment, and outcomes. Precision medicine (PM) programs have the potential to decrease
Read More
5 Forces Driving The Acceleration of Precision Medicine in 2019
The past several years has brought healthcare organizations closer and closer to integrating precision medicine and genomics into the daily business of care delivery. As an industry, we are nearly at the tipping point and I anticipate we will see significant acceleration towards this objective in 2019. Organizations will determine their precision medicine strategy, as well begin to develop operational processes defining how genomic data is managed and appropriately used.Progress in five
Read More
Syapse to Utilize NCCN Biomarkers Compendium for More Personalized Care
New partnership between National Comprehensive Cancer Network and Syapse will augment health information technology around cancer care. The National Comprehensive Cancer Network(NCCN) announced a new agreement with Syapse, a precision medicine company, to expand the use of best practices in precision medicine when treating people with cancer. Syapse delivers solutions for scaling enterprise precision oncology programs. For Syapse, the data contained in theNCCN Biomarkers Compendium will
Read More
Industry Roundtable: AI, Greater Collaboration, Integration are Key to Unlocking Healthcare Data’s Ability to Enhance Care Delivery
Chasm Partners, an executive search firm in the healthcare technology and services space recently convened a roundtable discussion to assess how the transformation of “big data” in clinical informatics provides the healthcare industry with an opportunity to gain new insights into patient care, as well as key lessons learned about artificial intelligence’s impact on the industry.Hosted as part of the firm’s quality newsletter, ChasmPOV featured viewpoints from three recognized thought leaders in
Read More
HMS’ Jennifer Forster Talks Leveraging Social Determinants of Health to Improve Population Health Outcomes
HMS’ Jennifer Forster explains how payers can cut costs and improve population health outcomes by incorporating social determinants of health (SDoH) into the mix.While the future of precision medicine is often associated with advances in genomics, there is more to consider when it comes to developing personalized treatment and PHM efforts. In fact, considering social determinants of health (SDoH), a recent and growing trend in predictive analytics, is gaining traction.A new study in Population
Read More
Hospital Culture: 4 Best Practices for Evidence-based Medicine Adoption
Does your organization follow evidence-based care guidelines? Do you currently utilize evidence-based content in your EHR? Do your clinicians embrace practices based on the best and most current clinical evidence?If your hospital has not yet fully adopted evidence-based medicine, yet wants to move in that direction, an important first step is to assess your organization’s readiness, starting with an examination of the hospital’s culture. As I travel across the country in my job, I often
Read More
Report: Precision Medicine Market Share to Cross $96B by 2024
The Precision Medicine Market size is set to exceed $96 billion dollars by 2024; according to a new research report by Global Market Insights. The new report reveals the rising prevalence of cancer across the globe fueling the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size.Advancement in cancer biology coupled with increased funding for cancer research will fuel industry
Read More